Barry J. Wolfenson
Corporate Officer/Principal bei MEDIWOUND LTD.
Profil
Barry J.
Wolfenson is the founder of Vtail Healthcare Communications.
He is currently the Chief Executive Officer at WoundForce, Inc. and a Director at Sano Diagnostics LLC.
Additionally, he is the Executive VP-Strategy & Corporate Development at MediWound Ltd.
starting in 2023.
Previously, he worked as a Marketing Manager-Convatec Division at Bristol Myers Squibb Co. and as the EVP-Global Marketing & Business Development at Derma Sciences, Inc. from 2011 to 2013.
Wolfenson received his undergraduate degree from Franklin & Marshall College in 1989 and his MBA from Stephen M.
Ross School of Business in 2001.
Aktive Positionen von Barry J. Wolfenson
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDIWOUND LTD. | Corporate Officer/Principal | 06.03.2023 |
Sano Diagnostics LLC
 Sano Diagnostics LLC Packaged SoftwareTechnology Services Sano Diagnostics LLC is an American company focused on improving clinical outcomes and quality of life by detecting inflammation earlier. The private company achieves this through their technology and data management solutions. The company provides news and contact information on their website. | Direktor/Vorstandsmitglied | 01.05.2019 |
| Vtail Healthcare Communications | Vorstandsvorsitzender | 01.03.2020 |
Ehemalige bekannte Positionen von Barry J. Wolfenson
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 27.10.2011 |
WoundForce, Inc.
 WoundForce, Inc. Miscellaneous Commercial ServicesCommercial Services WoundForce, Inc. operates as a specialty therapeutics organization. It develops a novel drug for wound debridement. The company is headquartered in Framingham, MA. | Vorstandsvorsitzender | 01.12.2021 |
| DERMA SCIENCES INC | Public Communications Contact | 27.10.2011 |
Ausbildung von Barry J. Wolfenson
| Franklin & Marshall College | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MEDIWOUND LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Derma Sciences, Inc.
 Derma Sciences, Inc. Medical SpecialtiesHealth Technology Derma Sciences, Inc. is a medical device company. It operates through the following product segments: Advanced Wound Care (AWC), Traditional Wound Care (TWC), and Other. The AWC segment includes both novel and otherwise differentiated dressings, devices, and skin substitutes designed to promote wound healing and prevent infection. The TWC segment focuses on commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners, and skin care products. The company was founded on September 10, 1984 and is headquartered in Princeton, NJ. | Health Technology |
WoundForce, Inc.
WoundForce, Inc. Miscellaneous Commercial ServicesCommercial Services WoundForce, Inc. operates as a specialty therapeutics organization. It develops a novel drug for wound debridement. The company is headquartered in Framingham, MA. | Commercial Services |
Sano Diagnostics LLC
Sano Diagnostics LLC Packaged SoftwareTechnology Services Sano Diagnostics LLC is an American company focused on improving clinical outcomes and quality of life by detecting inflammation earlier. The private company achieves this through their technology and data management solutions. The company provides news and contact information on their website. | Technology Services |
| Vtail Healthcare Communications |
